Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Racial Disparities in Mortality Rates among Patients with Hepatic Steatosis, Non-Alcoholic Fatty Liver Disease, and Non-Alcoholic Steatohepatitis

Insights from NHANES III Data

Bibliographic Data

ID2073631
AuthorsShahrzad Bazargan-Hejazi (0000-0001-8361-5198, Charles R. Drew University of Medicine and Science, corresponding author), Cameron Hines (0009-0001-6922-0680, Neurobehavioral Systems), Myra Usmani (University of California, Riverside), Chris Argueta (0000-0003-1243-3949, Charles R. Drew University of Medicine and Science), Deyu Pan (0000-0002-2218-2664, Charles R. Drew University of Medicine and Science), Arleen F Brown (0000-0001-9948-8955, Ronald Reagan UCLA Medical Center)
Year2025
Volume13
Issue2
Pages1083-1093
Publication date2025-03-04
Peer ReviewedYes
Open AccessYes
TypeARTICLE
VenueJournal of Racial and Ethnic Health Disparities (JOURNAL)
Journal identifiersISSN: 2196-8837 • E-ISSN: 2197-3792
PublisherSpringer Science and Business Media LLC (PUBLISHER)
DOI10.1007/s40615-025-02317-9
PMID40035953
OpenAlexW4408151598
LanguageEN
References cited23

Background Insufficient research has been done on NASH-related cirrhosis mortality and potential racial disparities in mortality rates. Objective This study aims to analyze racial differences in mortality rates among patients with non-alcoholic fatty liver disease (NAFLD), non-alcoholic fatty liver (NAFL), and non-alcoholic steatohepatitis (NASH), hypothesizing that hazard ratios for mortality among patients with NAFLD, NAFL, and NASH would be significantly different for Mexican American patients compared to other racial groups. Methods Data from NHANES III (1988-1994) representing the U.S. population were analyzed. Bivariate analysis and Cox proportional hazards models were employed to determine mortality rates and predictors across different racial/ethnic groups, adjusting for variables age, gender, smoking status (current, former, non-smoker), BMI (normal, overweight, obese), and a series of biomarkers. Results The prevalence of liver diseases in the sample was: NAFLD (12.1%), NAFL (20.0%), and NASH (3.1%). Deceased patients with NASH had the highest weighted mortality rate (50.6%), followed by NAFLD (39.1%) and NAFL (35.5%). Compared to White patients, Black and Mexican American patients exhibited lower mortality rates for NAFLD. Mexican American patients also had lower mortality rates for NFAL and NASH. White patients showed higher hazard ratios (HR) for NAFLD and NAFL compared to Black and Mexican-American patients. However, for NASH, there were no significant differences in HR between racial/ethnic groups. Conclusions Despite higher prevalence rates among Mexican American and Black patients, their mortality rates for NAFLD, NAFL, and NASH were comparable or lower than those for Whites. This highlights the need for further research to inform better management and treatment strategies

Alcoholic liver disease · Cirrhosis · Confidence interval · Disease · Environmental health · Fatty liver · Hazard ratio · Mortality rate · National Health and Nutrition Examination Survey · Population · Steatohepatitis · Demography · Liver Disease and Transplantation · Liver Disease Diagnosis and Treatment · Liver Diseases and Immunity · Medicine · Gastroenterology · Internal Medicine

  • Nonalcoholic Fatty Liver Disease and Ethnicity

    Open Access•Naim Abu‐Freha, Lior Eraki et al.•Journal of Immigrant and Minority…•2024

  • The Immigrant and Hispanic Paradoxes

    Open Access•Stacey A Teruya, Stacey Teruya et al.•Hispanic Journal of Behavioral…•2013

Citation velocityhistorical
Highly citedNo
Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae